-+ 0.00%
-+ 0.00%
-+ 0.00%

Barinthus Bio sets 0.111 share exchange ratio for Clywedog deal

PUBT·08/24/2026 22:57:48
Listen to the news
Barinthus Bio sets 0.111 share exchange ratio for Clywedog deal
  • Barinthus Biotherapeutics’ combination with Clywedog is now expected to take effect on Sept. 3, 2026.
  • Trading in Barinthus Bio ADSs on Nasdaq is expected to halt before the market opens on Sept. 3.
  • The scheme exchange ratio was set at 0.111 for Topco common stock issued in exchange for scheme shares.
  • Topco common stock is expected to begin trading on Nasdaq under the ticker CLYD once the deal closes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Barinthus Biotherapeutics plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608241857PRIMZONEFULLFEED9815323) on August 24, 2026, and is solely responsible for the information contained therein.